Home
>
National Drug Code (NDC)
>
Neupogen
Neupogen - 54868-2522-1 - (filgrastim)
Drug Information of Neupogen
| Product NDC: | 54868-2522 |
| Proprietary Name: | Neupogen |
| Non Proprietary Name: | filgrastim |
| Active Ingredient(s): | 300 ug/mL & nbsp; filgrastim |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Neupogen
| Product NDC: | 54868-2522 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103353 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19940608 |
Package Information of Neupogen
| Package NDC: | 54868-2522-1 |
| Package Description: | 10 VIAL in 1 PACKAGE (54868-2522-1) > 1 mL in 1 VIAL |
NDC Information of Neupogen
| NDC Code | 54868-2522-1 |
| Proprietary Name | Neupogen |
| Package Description | 10 VIAL in 1 PACKAGE (54868-2522-1) > 1 mL in 1 VIAL |
| Product NDC | 54868-2522 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | filgrastim |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19940608 |
| Marketing Category Name | BLA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | FILGRASTIM |
| Strength Number | 300 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
